(Sharecast News) - Shares in Moderna rallied on Thursday after third-quarter revenues at the US biotech, best known for its Covid-19 vaccine, smashed expectations.
In the three months to 30 September, revenues reached $1.86bn, marginally up on last year's $1.83bn and comfortably ahead of the $1.25bn expected.

The majority of...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE